Literature DB >> 24299686

When and why portal vein thrombosis matters in liver transplantation: a critical audit of 174 cases.

Taizo Hibi1, Seigo Nishida, David M Levi, Gennaro Selvaggi, Akin Tekin, Ji Fan, Phillip Ruiz, Andreas G Tzakis.   

Abstract

OBJECTIVE: To identify complications associated with different techniques utilized to treat portal vein thrombosis (PVT) during primary liver transplantation and their impact on survival.
BACKGROUND: PVT remains an intricate problem in liver transplantation, and the long-term outcomes of patients with PVT who undergo transplantation are not well defined.
METHODS: We performed a retrospective cohort analysis of all consecutive adult patients who underwent primary isolated liver transplantation from 1998 to 2009 (median follow-up period, 89 months). The outcomes of patients with PVT were compared with those without PVT.
RESULTS: Among 1379 recipients, 174 (12.6%) had PVT at the time of transplantation [83 (48%) complete and 91 (52%) partial]. Among PVT patients with reestablished physiological portal inflow (PVT: physiological group; n = 149), 123 underwent thrombectomies, 16 received interpositional vein grafts, and 10 received mesoportal jump grafts. In 25 patients, physiological portomesenteric venous circulation was not reconstituted (PVT: nonphysiological group; 18 underwent cavoportal hemitranspositions, 6 renoportal anastomoses, and 1 arterialization). The PVT: nonphysiological group suffered a significantly increased incidence of rethrombosis of the portomesenteric veins and gastrointestinal bleeding, with a marginal 10-year overall survival rate of 42% (no PVT, 61%; P = 0.002 and PVT: physiological, 55%; P = 0.043). The PVT: physiological and no PVT groups exhibited comparable survival rates (P = 0.13). No significant differences in survival were observed between complete and partial PVT as long as physiological portal flow was reestablished.
CONCLUSIONS: The subset of PVT patients requiring nonphysiological portal vein reconstruction was associated with higher complication rates and suffered diminished long-term prognoses. For the most severe PVT cases, a comprehensive approach is critical to further improve outcomes.

Entities:  

Mesh:

Year:  2014        PMID: 24299686     DOI: 10.1097/SLA.0000000000000252

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  33 in total

Review 1.  Management of Non-tumoral Portal Vein Thrombosis in Patients with Cirrhosis.

Authors:  Jonathan G Stine; Patrick G Northup
Journal:  Dig Dis Sci       Date:  2019-03       Impact factor: 3.199

Review 2.  Portal vein thrombosis in cirrhosis: Controversies and latest developments.

Authors:  Damian J Harding; M Thamara P R Perera; Frederick Chen; Simon Olliff; Dhiraj Tripathi
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

Review 3.  Vascular liver diseases on the clinical side: definitions and diagnosis, new concepts.

Authors:  Dominique-Charles Valla; Dominique Cazals-Hatem
Journal:  Virchows Arch       Date:  2018-03-24       Impact factor: 4.064

4.  Timing of Anticoagulation for Portal Vein Thrombosis in Liver Cirrhosis: A US Hepatologist's Perspective.

Authors:  Patrick G Northup; Jessica P E Davis
Journal:  J Transl Int Med       Date:  2018-03-28

5.  Timing of Anticoagulation for Portal Vein Thrombosis in Liver Cirrhosis: An Italian Internist's Perspective.

Authors:  Nicoletta Riva; Walter Ageno
Journal:  J Transl Int Med       Date:  2018-03-28

6.  Pre-transplant portal vein thrombosis is an independent risk factor for graft loss due to hepatic artery thrombosis in liver transplant recipients.

Authors:  Jonathan G Stine; Shawn J Pelletier; Timothy M Schmitt; Robert J Porte; Patrick G Northup
Journal:  HPB (Oxford)       Date:  2015-12-10       Impact factor: 3.647

7.  Balloon-Occlusion Technique for Managing Portal Vein Hemorrhage in Liver Transplantation.

Authors:  John B Seal; Humberto Bohorquez; Naren Battula; Lucia DeGregorio; Emily Bugeaud; David S Bruce; Ian C Carmody; Ari J Cohen; George E Loss
Journal:  Ochsner J       Date:  2017

Review 8.  Liver transplantation for hepatobiliary malignancies: a new era of "Transplant Oncology" has begun.

Authors:  Taizo Hibi; Osamu Itano; Masahiro Shinoda; Yuko Kitagawa
Journal:  Surg Today       Date:  2016-04-29       Impact factor: 2.549

9.  Portal vein thrombosis, mortality and hepatic decompensation in patients with cirrhosis: A meta-analysis.

Authors:  Jonathan G Stine; Puja M Shah; Scott L Cornella; Sean R Rudnick; Marwan S Ghabril; George J Stukenborg; Patrick G Northup
Journal:  World J Hepatol       Date:  2015-11-28

Review 10.  New Techniques and Devices in Transjugular Intrahepatic Portosystemic Shunt Placement.

Authors:  Jamie RiChard; Bartley Thornburg
Journal:  Semin Intervent Radiol       Date:  2018-08-06       Impact factor: 1.513

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.